Company & Sponsor Intelligence

University Hospital, Ghent

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials9

Recruiting0

Completed6

Countries1

Therapeutic footprint

depressionepilepsymigraine_headacheother_psychiatryparkinsonsstroke

Indexed studies

NCT02635633Continuous Thetaburst Stimulation for the Treatment of Refractory Epilepsy - Safety, Feasibility and Proof-of-concept
epilepsy · BelgiumNA

NCT01584934Sodium Oxybate in Patients With Chronic Fatigue Syndrome.
other_psychiatry · BelgiumPHASE4

NCT04650425Causal Evidence for Task Regulation by Anterior Cingulate Cortex
stroke · BelgiumNA

NCT05690308Visual Perturbation Training to Reduce Fall Risk in People with Parkinson's Disease
parkinsons · BelgiumNA

NCT03655366Epidogs International Inventory of Seizure Alert Dogs
epilepsy · BelgiumCOMPLETED

NCT05683028RCT for Electroconvulsive Treatment Followed by Cognitive Control Training
depression · BelgiumNA

NCT01645475Desmopressin Melt: Impact on Sleep and Daytime Functioning
other_psychiatry · BelgiumPHASE4

NCT01862952Continuous Video- EEG Monitoring in the Acute Phase in Patients With a Cerebrovascular Attack- Randomisation of a Subpopulation Regarding Treatment Strategy
stroke · BelgiumNA

NCT04983186mBrain-21 : a Three-month Study on Context-awareness, Physiological Monitoring, and Machine Learning in Migraine and Cluster Headache
migraine_headache · BelgiumNA

Intelligence layer updated: 2026-10-14 06:11:28.884102+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →